Belgium: Johnson & Johnson has announced that the European Commission has extended the marketing authorisation for TREMFYA ...

At close, the KSE-100 Index settled at 174,472.79, an increase of 576.45 points or 0.33%. Heavyweight stocks including OGDC, ...

The banking and financial sector witnessed a remarkable sequence of developments during the outgoing calendar year, ranging ...

("Takeda") is pleased to announce positive topline results for the two pivotal Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279) ...

Pakistan Refinery Limited (PSX: PRL) is a hydro-skimming refinery based in Karachi, Pakistan. Established in 1960, PRL ...

Trading activity was largely range bound, where the index touched the day's high at 172,168 and low at 170,859, indicating a ...

Our Data and News subscriptions grant you access to our extensive databases for Commercial and Business Aviation. You can ...

Earned Wage Access (EWA) offers a timely solution. It enables workers to access a portion of their earned wages before payday ...

Johnson & Johnson wins EU approval for Tremfya in pediatric plaque psoriasis, making it the first IL-23 inhibitor cleared for any pediatric condition.

Discover the existing tax-funded funds in Kenya as President William Ruto makes moves to establish a National Infrastructure ...

"Takeda to seek approval of plaque psoriasis pill on Phase III trial data" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

New York City-based 13D Management acquired 267,000 shares of Viasat in the third quarter. The shares were worth an estimated $7.82 million based on quarterly average pricing. Viasat is now the fund's ...